| Literature DB >> 27390291 |
Amir Karban1, Morad K Nakhleh2, John C Cancilla3, Rotem Vishinkin2, Tova Rainis4, Eduard Koifman1, Raneen Jeries2, Hodaya Ivgi2, Jose S Torrecilla3, Hossam Haick5.
Abstract
Chemical sensors based on programmable molecularly modified gold nanoparticles are tailored for the detection and discrimination between the breathprint of irritable bowel syndrome (IBS) and inflammatory bowel diseases (IBD). The sensors are examined in both lab- and real-world clinical conditions. The results reveal a discriminative power accuracy of 81% between IBD and IBS and 75% between Crohn's and Colitis states.Entities:
Keywords: breathprint; diagnosis; inflammatory bowel disease; irritable bowel syndrome; nanoparticles; sensors
Mesh:
Substances:
Year: 2016 PMID: 27390291 DOI: 10.1002/adhm.201600588
Source DB: PubMed Journal: Adv Healthc Mater ISSN: 2192-2640 Impact factor: 9.933